NO944145D0 - Antiiskemisk medikament - Google Patents

Antiiskemisk medikament

Info

Publication number
NO944145D0
NO944145D0 NO944145A NO944145A NO944145D0 NO 944145 D0 NO944145 D0 NO 944145D0 NO 944145 A NO944145 A NO 944145A NO 944145 A NO944145 A NO 944145A NO 944145 D0 NO944145 D0 NO 944145D0
Authority
NO
Norway
Prior art keywords
pct
enantiomer
date nov
sec
administered
Prior art date
Application number
NO944145A
Other languages
English (en)
Other versions
NO306236B1 (no
NO944145L (no
Inventor
Heimo Olavi Haikala
Reijo Johannes Backstroem
Erkki Juhani Honkanen
Jouko Mikael Levijoki
Pentti Tapio Nore
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO944145L publication Critical patent/NO944145L/no
Publication of NO944145D0 publication Critical patent/NO944145D0/no
Publication of NO306236B1 publication Critical patent/NO306236B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO944145A 1992-05-06 1994-10-31 Anvendelse av vasodilaterende forbindelse til fremstilling av antiiskemisk medikament NO306236B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9209769A GB2266841A (en) 1992-05-06 1992-05-06 Compounds for use as anti-ischemic medicaments
PCT/FI1993/000191 WO1993021921A1 (en) 1992-05-06 1993-05-05 Anti-ischemic medicament

Publications (3)

Publication Number Publication Date
NO944145L NO944145L (no) 1994-10-31
NO944145D0 true NO944145D0 (no) 1994-10-31
NO306236B1 NO306236B1 (no) 1999-10-11

Family

ID=10715082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944145A NO306236B1 (no) 1992-05-06 1994-10-31 Anvendelse av vasodilaterende forbindelse til fremstilling av antiiskemisk medikament

Country Status (25)

Country Link
US (1) US5512572A (no)
EP (1) EP0639074B1 (no)
JP (2) JP3313714B2 (no)
KR (1) KR100275823B1 (no)
AT (1) ATE196086T1 (no)
AU (1) AU665840B2 (no)
BG (1) BG61678B1 (no)
BR (1) BR9306314A (no)
CA (1) CA2134972C (no)
CZ (1) CZ283259B6 (no)
DE (1) DE69329381T2 (no)
DK (1) DK0639074T3 (no)
ES (1) ES2150445T3 (no)
FI (1) FI945052A (no)
GB (1) GB2266841A (no)
GR (1) GR3034896T3 (no)
HU (1) HU222349B1 (no)
NO (1) NO306236B1 (no)
NZ (1) NZ252693A (no)
PT (1) PT639074E (no)
RO (1) RO115781B1 (no)
RU (1) RU2146142C1 (no)
SK (1) SK279580B6 (no)
UA (1) UA35584C2 (no)
WO (1) WO1993021921A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI973804A (fi) * 1997-09-26 1999-03-27 Orion Yhtymae Oy Levosimendaanin oraalisia koostumuksia
FI974578A (fi) 1997-12-19 1999-06-20 Orion Yhtymae Oyj Menetelmä levosimendaanin antamiseksi
FI980902A (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI104718B (fi) * 1998-06-18 2000-03-31 Orion Yhtymae Oyj [[4-(2-atsido-3-metyyli-5-oksotetrahydrofuran-2-yyli)fenyyli]hydratsono]propaanidinitriili käytettäväksi referenssiaineena levosimendaanierien analyysissä
FI981473A (fi) 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
GB9915179D0 (en) * 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm
FI109659B (fi) 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
ATE282414T1 (de) 1999-10-22 2004-12-15 Orion Corp Neue verwendung von levosimendan
FI20001542A (fi) 2000-06-29 2001-12-30 Orion Yhtymae Oyj Menetelmä septisen sokin hoitamiseksi
FI20002526A (fi) * 2000-11-17 2002-05-18 Orion Yhtymae Oyj Pyridatsinonijohdannaisten uusi käyttö
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
JP2002211346A (ja) * 2001-01-15 2002-07-31 Takata Corp インフレータ
FI20010233A0 (fi) 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20020197A0 (fi) * 2002-02-01 2002-02-01 Orion Corp Yhdistelmä akuutin myokardiilisen infarktin hoitoon
US8618316B1 (en) 2004-03-05 2013-12-31 Stepan Company Low temperature ramp rate ester quat formation process
FI20040675A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä sydämen hypertrofian hoitoon ja estoon
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
EP1758584A1 (en) * 2004-05-28 2007-03-07 Abbott Laboratories Methods for treating a mammal before, during and after cardiac arrest
WO2012093404A2 (en) 2011-01-03 2012-07-12 Gufic Biosciences Limited Parenteral formulations of levosimendan
CN105784895B (zh) * 2015-10-30 2018-05-22 成都欣捷高新技术开发有限公司 一种用高效液相色谱仪检测左西孟旦中杂质的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962110A (en) * 1985-03-12 1990-10-09 Smith Kline & French Laboratories Limited Pyridazinone derivatives
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
FI884418A (fi) * 1987-10-05 1989-04-06 Fujisawa Pharmaceutical Co Hjaertskyddande aemne och ett terapeutiskt aemne foer ischemiska sjukdomar omfattande n-innehaollande heterocykliska foereningar, och ett foerfarande foer framstaellning av dessa foereningar.
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
US5109575A (en) * 1991-06-10 1992-05-05 Signode Corporation Toothed seal for hard thermoplastic strap

Also Published As

Publication number Publication date
RO115781B1 (ro) 2000-06-30
FI945052A0 (fi) 1994-10-27
CA2134972C (en) 2004-07-20
NO306236B1 (no) 1999-10-11
SK279580B6 (sk) 1999-01-11
BG61678B1 (bg) 1998-03-31
JP2002275067A (ja) 2002-09-25
CZ283259B6 (cs) 1998-02-18
BR9306314A (pt) 1998-06-30
AU4262793A (en) 1993-11-29
HU222349B1 (hu) 2003-06-28
NO944145L (no) 1994-10-31
PT639074E (pt) 2001-03-30
CA2134972A1 (en) 1993-11-11
DE69329381T2 (de) 2001-04-26
DK0639074T3 (da) 2000-10-09
US5512572A (en) 1996-04-30
ATE196086T1 (de) 2000-09-15
EP0639074A1 (en) 1995-02-22
SK132494A3 (en) 1995-11-08
HU9403191D0 (en) 1995-02-28
KR100275823B1 (ko) 2001-03-02
RU2146142C1 (ru) 2000-03-10
AU665840B2 (en) 1996-01-18
JPH07506354A (ja) 1995-07-13
UA35584C2 (uk) 2001-04-16
GR3034896T3 (en) 2001-02-28
EP0639074B1 (en) 2000-09-06
CZ272094A3 (en) 1995-02-15
JP3313714B2 (ja) 2002-08-12
FI945052A (fi) 1994-10-27
WO1993021921A1 (en) 1993-11-11
RU94046070A (ru) 1996-09-20
GB9209769D0 (en) 1992-06-17
GB2266841A (en) 1993-11-17
HUT68956A (en) 1995-08-28
BG99164A (bg) 1995-08-28
DE69329381D1 (de) 2000-10-12
ES2150445T3 (es) 2000-12-01
NZ252693A (en) 1997-07-27
KR950701223A (ko) 1995-03-23

Similar Documents

Publication Publication Date Title
NO944145L (no) Antiiskemisk medikament
GB2251615B (en) (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
EA200700232A1 (ru) Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения
ATE202076T1 (de) Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
HUP0001062A2 (hu) NAALADáz gátló hatású foszfinsavszármazékokat tartalmazó gyógyászati készítmények
EP0653936A1 (en) USE OF 2- (4- (4-CHLOROPHENYL) CYCLOHEXYL] -3-HYDROXY-1,4-NAPHTOQUINONE IN THE TREATMENT OF CANCER.
DE60312656D1 (de) Arzneimittel zur behandlung von störungen des zirkadianen rhythmus
NO20010984D0 (no) Anvendelse av R(+)-<alfa>-(2,3-dimetoksyfenyl)-1-[2-(4- fluorfenyl)etyl]-4-piperidinmetanol for behandling av søvnforstyrrelser
CA2543986A1 (en) Norepinephrine reuptake inhibitors and methods of using the same